Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
AstraZeneca head and neck cancer trials resume new patient enrolment as FDA lifts partial clinical hold
-
MedImmune completes out-licensing agreement with Allergan for MEDI2070
-
Year-to-date and Q3 2016 results
-
AstraZeneca head and neck cancer trials
-
Lynparza Phase III SOLO-2 trial shows significant progression-free survival benefit
-
FDA accepts for review New Drug Application for sodium zirconium cyclosilicate (ZS-9) for the treatment of hyperkalaemia
-
AstraZeneca enters agreement with Cilag GmbH International to divest rights to Rhinocort Aqua outside the US
-
AstraZeneca enters agreement with Aralez for beta-blocker medicine Toprol-XL in the US
-
AstraZeneca reports top-line results from the Brilinta EUCLID trial in patients with peripheral artery disease
-
MedImmune out-licenses potential medicine for inflammatory diseases to Allergan
Latest articles and press releases
All of our latest press releases and articles are available to explore
